A Pioneer Of Finance: At Tiie Intersection Of Investment Wisdom And Philanthropic Impulse. Global Financial Maven

GOOD Fellows AWARD Recipient, 2023
GOOD Fellows #2023

“Candice Beaumont stands as a monumental figure in the world of finance, exemplifying the very essence of the GOOD Fellows Awards. Her forward-thinking strategies and dedication to sustainable investment mirror the values that we hold in the highest regard.”

Lakshmi Narayanan,
Chairman, Sovereign Wealth Fund Institute

Candice Beaumont serves as Chairman of the Salsano Group, a Panama based family office & conglomerate invested in private equity. She is also Chief Investment Officer of L Investments, a single-family office invested in public and private equity. She oversees all capital allocation decisions for the internal fund of funds as well as the direct investment portfolio. Ms. Beaumont has been a speaker at numerous family office and invest­ment conferences globally and is a NYU Stern Family Office Council member serving on the Steering Commit­tee.

She also served on the Steering Committee of the Yale University School of Management College of Family Offices, as well as the Princeton University Council of Family Offices and Endowments. Ms.Beaumont is a member of the Board of Directors of numerous SPACs including Clean Earth Acquisition Corp. (Nasdaq: CLINU), Israel Acquisitions Corp (Nasdaq: ISRLU) is an Advisor to Athena Technology Acquisition Corp (NYSE: ATHN.U) and Advisor to Springwater Situations Corp. (NASDAQ: SWSSU).

She also serves on the board of GoLogiq, Inc. (OTC: GOLQ), a U.5.-based global provider of fintech and consumer data analytics. Candice is an Advisory Board member of the Family Office Association, a global mem­bership organization exclusive to single family offices and families of significant wealth, as well as a com­mittee member of the 1640 Society that caters to single family offices & ultra high net worth families. Candice was a member of the Board of Directors of I2BF Venture Fund II, a FSA regulated clean tech venture capital firm with offices in Dubai, New York, & London as well as an Advisory Board member of The Luxury Fund. 

She was also advisor to New Frontier Bio, a private investment arm of the Kennedy family, which co-founds, develops, and finances early stage innova­tive healthcare companies that have the potential to achieve validation, by transforming millions of lives and creating highly valuable businesses.